HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism.

AbstractAIMS/INTRODUCTION:
In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated.
MATERIAL AND METHODS:
The German nationwide inpatient sample of the years 2005-2018 was analyzed. Hospitalized PE patients were stratified for diabetes, and the impact of diabetes on in-hospital events was investigated.
RESULTS:
Overall, 1,174,196 PE patients (53.8% aged ≥70 years, 53.5% women) and, among these, 219,550 (18.7%) diabetes patients were included. In-hospital mortality rate amounted to 15.8%, and was higher in diabetes patients than in non-diabetes patients (19.8% vs 14.8%, P < 0.001). PE patients with diabetes had a higher prevalence of cardiovascular risk factors, comorbidities, right ventricular dysfunction (31.8% vs 27.7%, P < 0.001), prolonged in-hospital stay (11.0 vs 9.0 days, P < 0.001) and higher rates of adverse in-hospital events. Remarkably, diabetes was independently associated with increased in-hospital mortality (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.20-1.23, P < 0.001) when adjusted for age, sex and comorbidities. Within the observation period of 2005-2018, a relevant decrease of in-hospital mortality in PE patients with diabetes was observed (25.5% to 16.8%). Systemic thrombolysis was more often administered to diabetes patients (OR 1.18, 95% CI 1.01-3.49, P < 0.001), and diabetes was associated with intracerebral (OR 1.19, 95% CI 1.12-1.26, P < 0.001), as well as gastrointestinal bleeding (OR 1.11, 95% CI 1.07-1.15, P < 0.001). Type 1 diabetes mellitus was shown to be a strong risk factor in PE patients for shock, right ventricular dysfunction, cardiopulmonary resuscitation and in-hospital death (OR 1.75, 95% CI 1.61-1.90, P < 0.001).
CONCLUSIONS:
Despite the progress in diabetes treatments, diabetes is still associated with an unfavorable clinical patient profile and higher risk for adverse events, including substantially increased in-hospital mortality in acute PE.
AuthorsVolker H Schmitt, Lukas Hobohm, Visvakanth Sivanathan, Christoph Brochhausen, Tommaso Gori, Thomas Münzel, Stavros V Konstantinides, Karsten Keller
JournalJournal of diabetes investigation (J Diabetes Investig) Vol. 13 Issue 4 Pg. 725-737 (Apr 2022) ISSN: 2040-1124 [Electronic] Japan
PMID34779148 (Publication Type: Journal Article)
Copyright© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Topics
  • Acute Disease
  • Aged, 80 and over
  • Diabetes Mellitus (epidemiology)
  • Female
  • Germany (epidemiology)
  • Hospital Mortality
  • Humans
  • Male
  • Pulmonary Embolism (complications, epidemiology, therapy)
  • Retrospective Studies
  • Risk Factors
  • Thrombolytic Therapy (statistics & numerical data)
  • Ventricular Dysfunction, Right

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: